I’m on fire about Biostem U.S. Corp. (HAIR) today and the reason is in the ticker itself.
HAIR uses ethically harvested adult stem cells to super-charge balding scalps.
They say it’s virtually painless and you can do it on your lunch break.
You can imagine how much cash an outpatient cure for baldness would pull in!
And yet somehow HAIR is currently priced in the 20 cent range, so everyman traders like us still have a chance to see it on the ground floor.
See, HAIR is only now rolling its stem cell technique into hair transplant clinics in places like Orlando, Florida, where aging big shots want to stay young-looking forever.
HAIR will receive monthly revenue from each doctor who signs up.
Because they’re starting from near-zero here, every dollar moves the valuation needle.
And those first clinics just opened for stem cells a few weeks ago, so the inflection point here is as fresh as it gets!
Now that the wheels have finally started turning, HAIR could even become an attractive Big Biotech merger target.
After all, Propecia brings down $400 million a year for Merck.
And old Rogaine earned its maker $150 million a year back in the 90s.
The market is endless. Look for baldness cure online, 3 MILLION hits.
Just a few months ago, news that they’d found the cause of baldness drove the world wild.
A cure in five years? HAIR is already doing it!
HAIR is also turning heads as brokerage firms throw it cash for the privilege of getting their taste of this story before the Street catches on.
Elco Securities bought 20 million HAIR shares back in May at 25 cents apiece.
That’s a 65% premium over where HAIR was trading the day the deal was signed.
Remember, HAIR is now well under the $0.25 level so that position is still technically deep underwater.
Did the big boys at Elco get taken here or did they figure that $5 MILLION bet will be worth a lot more down the road?
All I know is that HAIR plans to use that cash to keep the lights on while its marketing team goes to work!
This board is stacked with top management from blue-chip corporations like Crocs.
Love or hate the shoes, Stephen Beck and Scott Crutchfield know how to build a multi-billion-dollar craze from the ground up, and they seem eager to do it again.
Bottom Line: HAIR just blasted out of the gate with a new revenue model and some of the biggest names in hair replacement on its team.
Smart players have gambled long green on this company and its technology.